Amsterdam, the Netherlands and London, UK – 1 May 2024 – Tessellate BIO, a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches, today announces the appointment of Professor Sandra Strauss, University College London, to its Scientific Advisory Board. The SAB, which recently convened a successful meeting in San Diego ahead of the […]